Skip to content
  • Print

Genentech Fellowship | Clinical Science – Non-Oncology Early Clinical Development

Genentech Logo gRED's OMNI Early Clinical Development (Genentech Research and Early Development) organization is responsible for developing and executing early development clinical strategies in healthy volunteers and patients to provide data for gRED non-oncology new molecular entities with respect to safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics and the utility of biomarkers. This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of Clinical Research. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities. Learn more about Genentech.

Fellows will spend 90% of their time on duties specific to the industry site and 10% of time on professional development activities with the Thomas J Long School of Pharmacy and Health Sciences. All fellows will be eligible for adjunct faculty status.

Fellowship Program Dates
The fellowship begins on July 1, 2018 and ends on June 30, 2020.

This position is currently not open for recruitment until Fall of 2019.